Finally listened to the Q1 announcement webcast over the weekend
- interesting to note that MSB expects both phase 3 readouts within a couple of weeks.
- webcast also seems to suggest that COVID ARDS readouts will trigger a significant proportion of the $505 million pre-commercialisation payments. Along those lines, I'd be expecting a milestone payment to be triggered once we get the 60% interim irrespective as to whether it is overwhelming efficacy or not (just needs to pass futility)
If we assumed COVID ARDS was $200 million of the 505 million, then it might be
- 60% interim (passes futility) - $20 million
- trial completion/overwhelming effiacy $50 million
- EUA - $50 million
- final BLA approval - $ 50 million
- additional markets ie EU - $30 million
All cause ARDS would be similar but with additional milestones along the lines of commencement of phase 3, earlier interims etc
Anyone have a sneaky suspicion that MSB might try to time one of the announcements with tomorrows AGM?
- Forums
- ASX - By Stock
- Ann: Mesoblast Corporate Update and Financial Results Webcast
Finally listened to the Q1 announcement webcast over the weekend...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.07 |
Change
-0.025(2.29%) |
Mkt cap ! $1.210B |
Open | High | Low | Value | Volume |
$1.10 | $1.13 | $1.05 | $8.152M | 7.517M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 76566 | $1.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.07 | 73154 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 76566 | 1.065 |
14 | 158322 | 1.060 |
2 | 165454 | 1.055 |
61 | 291116 | 1.050 |
5 | 55596 | 1.045 |
Price($) | Vol. | No. |
---|---|---|
1.070 | 73154 | 3 |
1.075 | 27474 | 2 |
1.080 | 63484 | 5 |
1.085 | 28221 | 3 |
1.090 | 106648 | 3 |
Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.07 |
  |
Change
-0.025 ( 2.84 %) |
|||
Open | High | Low | Volume | ||
$1.09 | $1.13 | $1.05 | 1873215 | ||
Last updated 15.59pm 10/05/2024 ? |
Featured News
MSB (ASX) Chart |